US

Incube Ventures closes third fund at $55.25 mln

San Jose, California-based Incube Ventures, a life science venture firm, has raised $55.25 million for its third fund, according to an SEC filing. No target was listed in the document.

Qualcomm rolls out $200 mln 5G fund

Qualcomm has launched a $200 million 5G ecosystem venture fund. The fund will invest in 5G startups.

VC-backed Attentive appoints Heymann as CTO

New York City-based Attentive, a personalized mobile messaging SaaS platform for brands and organizations, has named Harry Heymann as chief technical officer. Previously, he worked at Hometeam where he was vice president of engineering. Attentive's backers include Sequoia Capital, IVP, High Alpha, Bain Capital Ventures, Eniac Ventures and NextView Ventures.

Picus Security takes in $5 mln Series A

Picus Security, a cybersecurity firm, has raised $5 million in Series A funding Earlybird led the round.

EnsureDR nets $2.5 mln Series A

Silicon Valley-based EnsureDR, a disaster recovery readiness platform, has secured $2.5 million in Series A financing. Awz Ventures led the round.

Home insurance shopping platform Young Alfred inks $10 mln

New York City and Philadelphia-based Young Alfred, a home insurance shopping platform, has raised $10 million in funding. Gradient Ventures led the round with participation from Pear Ventures, ERA and Newfund Capital.

Lightspeed adds five to team

Lightspeed Venture Partners announced it has hired five people. Joining the team are COO David Baga and Partners Mercedes Bent, James Ephrati, Anoushka Vaswani and Rytis Vitkauskas. Bent will focus on consumer deals, while Ephrati and Vaswani will work on the growth team and Vitkauskas will be based in the U.K. and build out the firm's European practice.

Current takes in $20 mln Series B

Current, "the bank for modern life," has raised $20 million in Series B funding, according to a blog post on its site. The investors include Wellington Management Company, Galaxy Digital and CUNA Mutual Group.

Shiru grabs $3.5 mln seed

Shiru, a provider of proteins for food applications leveraging molecular design, has secured $3.5 million in seed funding. Lux Capital led the round.

VC-backed Cabaletta Bio begins trading on NASDAQ

Cabaletta Bio, a biotech company, has debuted its IPO after pricing its 6.8 million shares at $11 per share. The stock began trading October 25, 2019 on the NASDAQ under the ticker symbol "CABA." Morgan Stanley, Cowen and Evercore ISI are the lead underwriters. Cabaletta Bio's pre-IPO backers include 5 AM Ventures and Adage Capital Partners.